Health Spoken Here: Changing the Record
The electronic health record (EHR) landscape is evolving rapidly, with more than 80% adoption among providers and increasing annually. Technology advancements in EHR platforms are creating new opportunities for pharmaceutical companies to provide patient support, drive adherence, and incorporate clinical decision support services seamlessly at the point of care. As part of ghg’s Health Spoken Here discussion series, Changing the Record provides insights from industry leaders about how pharmaceutical companies are employing EHRs in new ways to better support providers and improve outcomes for patients.
Click here to view the entire article and learn how brands can benefit from innovative EHR strategies.
ghg Launches Health Spoken Here Series
Among the many goals of the Affordable Care Act (ACA) is to rein in the ever-rising cost of healthcare in the U.S., making all providers of care more accountable for the cost, quality, and value of what they deliver. How will the ACA accomplish this and drive value in the healthcare system?
On May 27th, ghg and market access consultancy WG Consulting partnered to host a panel discussion focusing on the ACA’s core value proposition. To lead this evolving debate, key influencers from across the healthcare spectrum came together and debated how the ACA will – or will not – change the way the health care system determines value.
Click here to read more about navigating the value-based paradigm.